Browsing by Author "Klisic, A. (56160473800)"
Now showing 1 - 3 of 3
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication A NON-INVASIVE METHOD FOR ESTIMATING THE SEVERITY OF LIVER STEATOSIS AND THE RISK OF FIBROSIS IN NON-OBESE TYPE 2 DIABETES PATIENTS WITH NAFLD(2022) ;Mitrovic, B. (57211280115) ;Gluvic, Z. (24460256500) ;Klisic, A. (56160473800) ;Obradovic, Milan (48061421600) ;Macut, D. (35557111400) ;Tomasevic, R. (6603547250)Isenovic, E.R. (14040488600)Context. Prognostic considerations include assessing the risk of liver fibrosis in people with non-alcoholic fatty liver disease (NAFLD). Objectives. This study evaluates the use of hematologic and metabolic parameters regarding liver steatosis and fibrosis scores (FLI and Fib-4) in non-obese type 2 diabetes mellitus (t2DM) patients with NAFLD. Methods. Subjects underwent abdominal ultrasound examinations, and FLI and Fib-4 scores were calculated to evaluate liver steatosis and the risk of liver fibrosis non-invasively: 61 non-obese NAFLD subjects with t2DM were included in the cohort study and were divided into 2 groups depending on the t2DM treatment regimen. Results. Fib-4 and WBC count demonstrated a significant inverse correlation (OR = 0.509, p = 0.007). WBC count had an R2 of 0.237, indicating that this marker could account for up to 23.7% of a variation in Fib-4. Fib-4 and FFA had positive correlation which did not achieve statistically significant prediction (OR=7.122, p=0.062). Additionally, a significant prediction of HbA1c (OR=1.536, p=0.016) and haemoglobin (OR=1.071, p=0.020) for FLI was revealed. Conclusion. HbA1c and other haematological and metabolic parameters, such as haemoglobin and WBC, may be another non-invasive tool for determining whether non-obese NAFLD patients with t2DM are at risk of developing liver steatosis and fibrosis. © 2022, Acta Endocrinologica Foundation. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication A NON-INVASIVE METHOD FOR ESTIMATING THE SEVERITY OF LIVER STEATOSIS AND THE RISK OF FIBROSIS IN NON-OBESE TYPE 2 DIABETES PATIENTS WITH NAFLD(2022) ;Mitrovic, B. (57211280115) ;Gluvic, Z. (24460256500) ;Klisic, A. (56160473800) ;Obradovic, Milan (48061421600) ;Macut, D. (35557111400) ;Tomasevic, R. (6603547250)Isenovic, E.R. (14040488600)Context. Prognostic considerations include assessing the risk of liver fibrosis in people with non-alcoholic fatty liver disease (NAFLD). Objectives. This study evaluates the use of hematologic and metabolic parameters regarding liver steatosis and fibrosis scores (FLI and Fib-4) in non-obese type 2 diabetes mellitus (t2DM) patients with NAFLD. Methods. Subjects underwent abdominal ultrasound examinations, and FLI and Fib-4 scores were calculated to evaluate liver steatosis and the risk of liver fibrosis non-invasively: 61 non-obese NAFLD subjects with t2DM were included in the cohort study and were divided into 2 groups depending on the t2DM treatment regimen. Results. Fib-4 and WBC count demonstrated a significant inverse correlation (OR = 0.509, p = 0.007). WBC count had an R2 of 0.237, indicating that this marker could account for up to 23.7% of a variation in Fib-4. Fib-4 and FFA had positive correlation which did not achieve statistically significant prediction (OR=7.122, p=0.062). Additionally, a significant prediction of HbA1c (OR=1.536, p=0.016) and haemoglobin (OR=1.071, p=0.020) for FLI was revealed. Conclusion. HbA1c and other haematological and metabolic parameters, such as haemoglobin and WBC, may be another non-invasive tool for determining whether non-obese NAFLD patients with t2DM are at risk of developing liver steatosis and fibrosis. © 2022, Acta Endocrinologica Foundation. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Paraoxonase 1 low activity and SYNTAX score may predict postoperative complications after coronary artery surgery(2021) ;Vukicevic, P. (57190574629) ;Klisic, A. (56160473800) ;Kotur-Stevuljevic, J. (6506416348) ;Mikic, A. (57214281171) ;Bogavac-Stanojevic, N. (6506171691) ;Matkovic, M. (57113361300) ;Putnik, S. (16550571800) ;Aleksic, N. (57209310510) ;Tutus, V. (57196079539)Karikas, G.A. (6701422363)OBJECTIVE: Coronary artery bypass grafting (CABG) seems to present a powerful trigger of oxidative stress (OS) and acute inflammatory response. This study aimed to estimate the effects of off-pump coronary artery bypass (OPCAB) grafting on the OS that is commonly observed in patients undergoing operation under cardiopulmonary bypass (CPB). Additionally, we aimed to examine the relationship between and paraoxonase 1 (PON1) activity and the degree of stenosis, severity and complexity of the atherosclerotic lesions, estimated by SYNTAX score (SS). PATIENTS AND METHODS: Study group of 107 patients scheduled for CABG were divided into CPB and OPCAB group. Blood samples for OS markers measurement were collected at six-time intervals: before skin incision (t1), immediately after surgery (t2), 6h (t3), 24h (t4), 48h (t5) and 96h after cessation of the operation and surgical trauma (t6). SS was calculated. RESULTS: A significant decrease in lipid hydroperoxides (LOOH) and advanced oxidation protein products (AOPP) levels after both types of surgeries were observed, whereas PON1 reduction was observed higher in the CPB than in the OPCAB group. A significant inverse correlation between SS values and PON1 activity, preoperatively and during the early postoperative hours after surgery [in t2, t3 time intervals (p<0.05 for all)] was found. ROC analysis showed that for CPB patients, Model with all OS parameters showed excellent accuracy (AUC=0.957, p<0.001) for prediction postoperative complications. CONCLUSIONS: Decrease in PON1 activity during the early post-operative phases was related to higher SS. This relationship was more convincing in CPB, compared with OPCAB patients. Moreover, integrated models of OS status parameters have the capability to predict the development of postoperative complications. © 2021 Verduci Editore s.r.l. All rights reserved.
